UTHSC researchers identify three drugs as possible therapeutics for COVID-19

Updated:4 years, 11 months ago

New Delhi, Nov 20 (ANI): Three drugs, already approved for other uses in humans, have been identified as possible therapeutics for COVID-19, the illness caused by the SARS-CoV-2 virus. The finding is a product of work by researchers at the University of Tennessee Health Science Center (UTHSC) collaborating with those at the University of New Mexico. Based on virtual and in vitro antiviral screening that began in the earlier months of the Covid-19 pandemic, the researchers led at UTHSC by Colleen Jonsson, PhD, identified zuclopenthixol, nebivolol, and amodiaquine as promising therapeutics for the virus in its early stages. Dr. Jonsson is a professor and the Endowed Van Vleet Chair of Excellence in Virology in the College of Medicine at UTHSC. She also directs the UTHSC Regional Biocontainment Laboratory (RBL), where this research was conducted. The university's RBL is one of roughly a dozen federally funded labs authorized to safely study contagious pathogens. In a paper published in ACS Pharmacology and Translational Science, the researchers propose the drugs as possible candidates for testing in future clinical trials to improve immune response to the virus. Amodiaquine is an older antimalarial, zuclopenthixol is an antipsychotic, and nebivolol is a blood pressure medication.

Top Videos

Updated:4 years, 9 months ago

Pan-India dry run for COVID vaccine tomorrow: Harsh Vardhan

Updated:4 years, 9 months ago

PM Modi joins world leaders in condemning US Capitol siege

Updated:4 years, 10 months ago

Indo-Japan Samvad: Buddha’s message spread out from India to world, says PM Modi

Updated:4 years, 10 months ago

Centre preparing with states for past 4 months for COVID-19 vaccination: Harsh Vardhan

Updated:4 years, 10 months ago

In Jan, India may be in position to give 1st COVID vaccine shot: Harsh Vardhan

Updated:4 years, 10 months ago

Worst is over but still need to be cautious: Health Minister on COVID-19 cases in India

UTHSC researchers identify three drugs as possible therapeutics for COVID-19

Top Videos

Related Video

Aggressive intervention recommended to prevent pediatric diabetes, finds study

Study reveals high fat diets may over-activate destructive heart disease protein

Consuming diet high in poor quality carbohydrates linked to heart attacks, death risk

Researchers find light activities may help women's mobility during ageing

COVID antibodies are transferred from pregnant women to their babies

Overweight, diabetic people at risk of developing nonalcoholic fatty liver disease

Study reveals factors linked with elevated risk of bone fracture

Damage to heart found in more than half of COVID-19 patients discharged from hospital

LGB people more prone to mental health disorders, alcohol misuse

Unacceptably high levels of carcinogens inhaled by commuters

Post-surgery in kids, aspirin preferred to prevent blood clots

Coffee consumption related with decreased heart failure risk

Study reveals high blood pressure causes atrial fibrillation

Greater retail availability of marijuana, alcohol linked with co-use among teens

COVID-19 patients have higher risk of dying after cardiac arrest

World Cancer Day: Understanding role of nutrition, lifestyle changes to control cancer

Pregnancy complications increase risk of heart disease in women

Antibiotic may improve depressive symptoms in people with low-level inflammation: Study

Serious complications during pregnancy linked to higher risk of death: Study

Study reveals what causes irritable bowel syndrome